Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 761 of 1,261
  1. US 8987426

    Immunotoxin fusion proteins and means for expression thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  2. US 8987332

    Methods of treating inflammatory conditions

    The Regents of the University of California · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  3. US 8987308

    Compounds for the treatment of Clostridium difficile-associated disease

    Summit Corporation Plc · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  4. US 8987309

    Compounds, pharmaceutical compositions and methods of use of 2-aryl pyridylazoles

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  5. US 8987296

    Acridone compounds

    The United States of America DBA The Department of Veterans Affairs · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  6. US 8987289

    Methods for treating pruritus

    Trevi Therapeutics, Inc. · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  7. US 8987294

    Small molecule inhibitors of the α4-paxillin interaction

    The Regents of the University of California · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  8. US 8987227

    Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of use

    Alnylam Pharmaceuticals, Inc. · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  9. US 8987228

    Pharmaceutical composition including an A3 adenosine receptor agonist 1-deooxy-1-[N6-(3-idobenzyl)-adenin-9-yl]-N-methyl-β-D-ribofuronamide(IB-MECA/CF-101) for treatment of psoriasis

    CAN-FITE BIOPHARMA LTD. · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  10. US 8987198

    Compositions and methods for treating obesity and diabetes

    United States Department of Agriculture · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  11. US 8987192

    Potent and selective mediators of cholesterol efflux

    The Regents of the University of California · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  12. US 8987189

    Treating hepatitis C virus infection

    The Board of Regents of the University of Texas System · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  13. US 8987216

    Polysulfated glycosides and salts thereof

    Teva Hungary Pharmaceutical Marketing Private Limited Company · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  14. US 8986935

    Methods for treating spinal muscular atrophy

    PTC THERAPEUTICS, INC. · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  15. US 8986757

    Essential oils inhibit mold on wood

    The United States of America, as represented by the Secretary of Agriculture · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  16. US 8986701

    Enzyme prodrug cancer therapy selectively targeted to tumor vasculature and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  17. US 8986708

    Combinations of gene deletions for live attenuated Shigella vaccine strains

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  18. US 8986688

    WAP domain fusion polypeptides and methods of use thereof

    Inhibrx, Inc. · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  19. US 8986736

    Method for delivering particulate drugs to tissues

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  20. US 8986005

    Strip for transferring a therapeutic composition to a tooth

    DISCUS DENTAL, LLC · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  21. US 8986737

    Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth

    The Board of Regents of the University of Texas System · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  22. US 8987237

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  23. US 8987238

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  24. US 8987305

    2,4,5-trisubstituted imidazoles and their use as anti-microbial agents

    APTOSE BIOSCIENCES INC. · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.